COVID-19 in people with diabetes: understanding the reasons for worse outcomes
Open Access
- 17 July 2020
- journal article
- research article
- Published by Elsevier BV in The Lancet Diabetes & Endocrinology
- Vol. 8 (9), 782-792
- https://doi.org/10.1016/s2213-8587(20)30238-2
Abstract
No abstract availableThis publication has 96 references indexed in Scilit:
- Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMCNature, 2013
- Risk of pneumonia associated with use of angiotensin converting enzyme inhibitors and angiotensin receptor blockers: systematic review and meta-analysisBMJ, 2012
- Trends in the quality of care for elderly people with type 2 diabetes: The need for improvements in safety and quality (the 2001 and 2007 ENTRED Surveys)Diabetes & Metabolism, 2011
- Hypoglycemia Induced by Hydroxychloroquine in a Patient Treated for Rheumatoid ArthritisJCR: Journal of Clinical Rheumatology, 2011
- Pioglitazone, a Peroxisome Proliferator-Activated Receptor Gamma Ligand, Suppresses Bleomycin-Induced Acute Lung Injury and FibrosisRespiration, 2008
- Ketosis-Prone Type 2 Diabetes Mellitus and Human Herpesvirus 8 Infection in Sub-Saharan AfricansJAMA, 2008
- Not so fast: adaptive suppression of innate immunityNature Medicine, 2007
- Hepatotoxicity and antiretroviral therapy with protease inhibitors: A reviewDigestive and Liver Disease, 2006
- Angiotensin II AT1 receptors regulate ACE2 and angiotensin-(1–7) expression in the aorta of spontaneously hypertensive ratsAmerican Journal of Physiology-Heart and Circulatory Physiology, 2005
- Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesisThe Journal of Pathology, 2004